Serum levels of vascular endothelial growth factor in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
Vascular endothelial growth factor in sera of patients with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 330s Year: 2005
The role of serum adhesion molecules and vascular endothelial growth factor in the treatment approach of the lung cancer patients Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
Expression of vascular endothelial-cadherin and vascular endothelial growth factor in non-small cell lung cancer and their clinical significances Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) as a prognostic factor of survival in patients with lung adenocarcinoma Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
Vascular endothelial growth factor and oxidative stress in patients with primary lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007
The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018
Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung Source: Eur Respir J 2006; 28: Suppl. 50, 822s Year: 2006
Overexpression of fibroblast growth factor and down-regulation of platelet-derived growth factor correlate with advanced-stage lung fibrosis Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010
The effect of matrix metalloproteinase-9 and vascular endothelial growth factor expression on survival of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Prognostic significance of epidermal growth factor receptor expression in nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002
Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro Source: Eur Respir J 2002; 20: 1449-1456 Year: 2002
Tissue levels of platelet-derived endothelial cell growth factor/thymidine phosphorylase, vascular endothelial growth factor and cathepsin-D in patients with brochogenic cancer Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005
The prognostic value of serum epidermal growth factor receptor (EGFR) levels in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004
Inverse correlation between the expression of vascular endothelial growth factor and infiltration of dendritic cells and their influence on the prognosis of nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 13s Year: 2002
Vascular endothelial growth factor (VEGF) mRNA isoforms in an animal model of acute lung injury Source: Annual Congress 2003 - Animal models of lung injury: useful or not? Year: 2003
Expression of vascular endothelial growth factor (VEGF) and its receptors (VEFG-R1-Flt1, VEGF-R2-Flk1) in non small cell lung carcinomas (NSCLC): correlation with lymphangiogenesis and clinical outcome Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007
Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in NSCLC Source: Eur Respir J 2005; 26: Suppl. 49, 459s Year: 2005
Prognostic significance of serum vascular endothelial growth factor and angiopoietin-2 in lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013
Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer Source: Eur Respir J 2005; 25: 329-335 Year: 2005